End-of-day quote
Dhaka S.E.
06:00:00 2024-07-07 pm EDT
|
5-day change
|
1st Jan Change
|
20.4
BDT
|
0.00%
|
|
+11.48%
|
-27.66%
|
Fiscal Period: Giugno |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,848
|
2,577
|
2,137
|
2,595
|
2,443
|
2,464
|
Enterprise Value (EV)
1 |
2,825
|
2,532
|
2,129
|
2,545
|
2,976
|
3,634
|
P/E ratio
|
10.7
x
|
12.3
x
|
29.6
x
|
-76.1
x
|
-29
x
|
-10.1
x
|
Yield
|
-
|
-
|
1.02%
|
0.84%
|
-
|
-
|
Capitalization / Revenue
|
2.13
x
|
2.17
x
|
2.82
x
|
4.39
x
|
70
x
|
4.54
x
|
EV / Revenue
|
2.11
x
|
2.13
x
|
2.81
x
|
4.3
x
|
85.3
x
|
6.7
x
|
EV / EBITDA
|
8.47
x
|
9.37
x
|
16.6
x
|
129
x
|
-73
x
|
-40.8
x
|
EV / FCF
|
-28.8
x
|
-45.4
x
|
-33.2
x
|
32.4
x
|
-5.24
x
|
-6.75
x
|
FCF Yield
|
-3.47%
|
-2.2%
|
-3.01%
|
3.09%
|
-19.1%
|
-14.8%
|
Price to Book
|
1.03
x
|
0.87
x
|
0.7
x
|
0.87
x
|
0.93
x
|
1.03
x
|
Nbr of stocks (in thousands)
|
218,093
|
218,093
|
218,093
|
218,093
|
218,093
|
218,093
|
Reference price
2 |
13.06
|
11.82
|
9.800
|
11.90
|
11.20
|
11.30
|
Announcement Date
|
8/29/18
|
12/5/19
|
10/28/20
|
10/31/21
|
11/24/22
|
11/22/23
|
Fiscal Period: Giugno |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,337
|
1,187
|
756.7
|
591.7
|
34.87
|
542.6
|
EBITDA
1 |
333.4
|
270.3
|
128.3
|
19.73
|
-40.76
|
-89.11
|
EBIT
1 |
267
|
209.6
|
73.03
|
-30.52
|
-86.52
|
-220.3
|
Operating Margin
|
19.97%
|
17.66%
|
9.65%
|
-5.16%
|
-248.1%
|
-40.6%
|
Earnings before Tax (EBT)
1 |
266.7
|
209.2
|
72.14
|
-30.95
|
-79.05
|
-239.9
|
Net income
1 |
266.7
|
209.2
|
72.14
|
-34.13
|
-84.2
|
-244.9
|
Net margin
|
19.94%
|
17.63%
|
9.53%
|
-5.77%
|
-241.45%
|
-45.13%
|
EPS
2 |
1.223
|
0.9590
|
0.3308
|
-0.1565
|
-0.3861
|
-1.123
|
Free Cash Flow
1 |
-98.08
|
-55.77
|
-64.18
|
78.61
|
-568.2
|
-538.5
|
FCF margin
|
-7.33%
|
-4.7%
|
-8.48%
|
13.29%
|
-1,629.44%
|
-99.25%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
398.36%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
0.1000
|
0.1000
|
-
|
-
|
Announcement Date
|
8/29/18
|
12/5/19
|
10/28/20
|
10/31/21
|
11/24/22
|
11/22/23
|
Fiscal Period: Giugno |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
533
|
1,170
|
Net Cash position
1 |
23
|
45.7
|
8.59
|
50.7
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-13.08
x
|
-13.13
x
|
Free Cash Flow
1 |
-98.1
|
-55.8
|
-64.2
|
78.6
|
-568
|
-538
|
ROE (net income / shareholders' equity)
|
10.1%
|
7.29%
|
2.4%
|
-1.13%
|
-2.99%
|
-9.73%
|
ROA (Net income/ Total Assets)
|
6.23%
|
4.49%
|
1.49%
|
-0.61%
|
-1.63%
|
-3.76%
|
Assets
1 |
4,284
|
4,659
|
4,832
|
5,635
|
5,182
|
6,521
|
Book Value Per Share
2 |
12.70
|
13.60
|
14.00
|
13.70
|
12.10
|
11.00
|
Cash Flow per Share
2 |
0.1000
|
0.2100
|
0.0500
|
1.140
|
1.220
|
0.5500
|
Capex
1 |
313
|
232
|
143
|
440
|
1,172
|
84.1
|
Capex / Sales
|
23.39%
|
19.53%
|
18.94%
|
74.38%
|
3,359.72%
|
15.5%
|
Announcement Date
|
8/29/18
|
12/5/19
|
10/28/20
|
10/31/21
|
11/24/22
|
11/22/23
|
|
1st Jan change
|
Capi.
|
---|
| -27.66% | 26.55M | | +22.45% | 68.02B | | -5.52% | 46.34B | | +23.56% | 43.77B | | +38.26% | 28.93B | | +13.58% | 19.86B | | +13.91% | 17.23B | | -25.63% | 14.95B | | -13.76% | 14.44B | | -31.09% | 11.82B |
Other Specialty Chemicals
|